n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine has been researched along with Hyperesthesia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browne, JL; Pilcher, CW | 1 |
1 other study(ies) available for n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine and Hyperesthesia
| Article | Year |
|---|---|
Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus.
Topics: Analgesia; Animals; Benzomorphans; Enkephalin, Leucine; Hyperalgesia; Hyperesthesia; Injections, Spinal; Male; Morphinans; Naloxone; Narcotic Antagonists; Pain; Rats; Receptors, Opioid | 1986 |